Chemoinformaics analysis of 2,4,8,9-TETRAHYDROXY-[1]BENZOFURO[3,2-C]CHROMEN-6-ONE
| Molecular Weight | 300.222 | nRot | 0 |
| Heavy Atom Molecular Weight | 292.158 | nRig | 1 |
| Exact Molecular Weight | 300.027 | nRing | 4 |
| Solubility: LogS | -1.073 | nHRing | 2 |
| Solubility: LogP | 1.218 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 17 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 20 |
| nHA | 7 | APOL | 35.9983 |
| nHD | 4 | BPOL | 12.3657 |
| QED | 0.485 |
| Synth | 1.639 |
| Natural Product Likeliness | 0.383 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.028 |
| HIA | 0.003 |
| CACO-2 | -4.218 |
| MDCK | 0.0000347 |
| BBB | 0.997 |
| PPB | 0.228477 |
| VDSS | 0.809 |
| FU | 0.776938 |
| CYP1A2-inh | 0.792 |
| CYP1A2-sub | 0.653 |
| CYP2c19-inh | 0.205 |
| CYP2c19-sub | 0.859 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.671 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.433 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.254 |
| CL | 9.839 |
| T12 | 0.888 |
| hERG | 0.018 |
| Ames | 0.015 |
| ROA | 0.046 |
| SkinSen | 0.444 |
| Carcinogencity | 0.121 |
| EI | 0.985 |
| Respiratory | 0.096 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.604205 |